JTE-051

N/A

Report date: 2023/06/25 20:00:45
NME

Base Information

Drug NameJTE-051
Drug Alias NameJTE-051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsPlaque psoriasisSkin DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAkros Pharma Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisSkin DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A